These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 6097158

  • 1. Beneficial effects of interleukin-2 on natural killer activity in lung cancer patients.
    Ito M, Suzuki H, Yamashita N, Sugiyama E, Maruyama M, Sato M, Iwata M, Yano S.
    Anticancer Res; 1984; 4(6):375-8. PubMed ID: 6097158
    [Abstract] [Full Text] [Related]

  • 2. Cytotoxicity tests against cultured human lung cancer cells with autologous lymphocytes activated in vitro by mitomycin C-treated tumor monolayers in the presence of T-cell growth factor.
    Kimura H, Yamaguchi Y, Kadoyama C, Sato N, Fujisawa T.
    Jpn J Clin Oncol; 1983 Mar; 13(1):3-13. PubMed ID: 6300483
    [Abstract] [Full Text] [Related]

  • 3. Phenotype and function of natural killer cells in patients with bronchogenic carcinoma.
    LeFever AV, Funahashi A.
    Cancer Res; 1991 Oct 15; 51(20):5596-601. PubMed ID: 1655257
    [Abstract] [Full Text] [Related]

  • 4. Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism.
    Rook AH, Hooks JJ, Quinnan GV, Lane HC, Manischewitz JF, Macher AM, Masur H, Fauci AS, Djeu JY.
    J Immunol; 1985 Mar 15; 134(3):1503-7. PubMed ID: 3918102
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Lysis of fresh human tumor cells by autologous large granular lymphocytes and T-lymphocytes: two distinct killing activities induced by coculture with autologous tumor.
    Uchida A, Moore M.
    J Natl Cancer Inst; 1984 Dec 15; 73(6):1285-92. PubMed ID: 6239944
    [Abstract] [Full Text] [Related]

  • 12. [The effect of sera of breast cancer patients on NK cell activity].
    Konjević G, Spuzić I.
    Srp Arh Celok Lek; 1995 Dec 15; 123(9-10):227-31. PubMed ID: 17974436
    [Abstract] [Full Text] [Related]

  • 13. Pretreatment of human peripheral blood lymphocytes with interleukin-2 or dexamethasone does not alter their response to Met-Enkephalin in a NK-cytotoxic assay.
    Martin-Kleiner I, Gabrilovac J.
    Immunopharmacol Immunotoxicol; 1996 Feb 15; 18(1):37-57. PubMed ID: 8683038
    [Abstract] [Full Text] [Related]

  • 14. Low dose subcutaneous interleukin-2 after autologous transplantation generates sustained in vivo natural killer cell activity.
    Miller JS, Tessmer-Tuck J, Pierson BA, Weisdorf D, McGlave P, Blazar BR, Katsanis E, Verfaillie C, Lebkowski J, Radford J, Burns LJ.
    Biol Blood Marrow Transplant; 1997 Apr 15; 3(1):34-44. PubMed ID: 9209739
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Role of natural killer cells in cancer.
    Pross HF, Lotzová E.
    Nat Immun; 1993 Apr 15; 12(4-5):279-92. PubMed ID: 8257832
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.